{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "6307140",
  "DateCompleted": {
    "Year": "1983",
    "Month": "08",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0166-3542",
      "JournalIssue": {
        "Volume": "3",
        "Issue": "1",
        "PubDate": {
          "Year": "1983",
          "Month": "Mar"
        }
      },
      "Title": "Antiviral research",
      "ISOAbbreviation": "Antiviral Res"
    },
    "ArticleTitle": "Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha 2.",
    "Pagination": {
      "StartPage": "67",
      "EndPage": "71",
      "MedlinePgn": "67-71"
    },
    "Abstract": {
      "AbstractText": [
        "Isolation of rhinoviruses from nasal secretions may be delayed or prevented by exogenously applied interferon which is carried over into nasal wash specimens. In studies of interferon-alpha 2 treated volunteers with experimental rhinovirus infection, we determined that incorporation of antiinterferon antibody into collection broth significantly increased isolation rates (84% increase) and the proportion of monolayers positive for CPE (155% increase), as compared to plain collection broth."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hayden",
        "ForeName": "F G",
        "Initials": "FG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gwaltney",
        "ForeName": "J M",
        "Initials": "JM",
        "Suffix": "Jr"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R23-AI170-34",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Antiviral Res",
    "NlmUniqueID": "8109699",
    "ISSNLinking": "0166-3542"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Interferon Type I"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Antibodies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cells, Cultured"
    },
    {
      "QualifierName": [
        "immunology",
        "microbiology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cytopathogenic Effect, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "immunology",
        "pharmacology"
      ],
      "DescriptorName": "Interferon Type I"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Rhinovirus"
    }
  ]
}